These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25199968)

  • 1. Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: a systematic review and meta-analysis.
    Gu WJ; Wang F; Tang L; Bakker J; Liu JC
    Int J Antimicrob Agents; 2014 Dec; 44(6):477-85. PubMed ID: 25199968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis.
    Liu D; Zhang J; Liu HX; Zhu YG; Qu JM
    Int J Antimicrob Agents; 2015 Dec; 46(6):603-9. PubMed ID: 26607337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous vs intravenous plus aerosolized colistin for treatment of ventilator-associated pneumonia - a matched case-control study in neonates.
    Hussain K; Salat MS; Ambreen G; Mughal A; Idrees S; Sohail M; Iqbal J
    Expert Opin Drug Saf; 2020 Dec; 19(12):1641-1649. PubMed ID: 32892635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria.
    Tumbarello M; De Pascale G; Trecarichi EM; De Martino S; Bello G; Maviglia R; Spanu T; Antonelli M
    Chest; 2013 Dec; 144(6):1768-1775. PubMed ID: 23989805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial.
    Liu C; Zhang YT; Peng ZY; Zhou Q; Hu B; Zhou H; Li JG
    Chin Med J (Engl); 2017 May; 130(10):1196-1201. PubMed ID: 28485320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study.
    Kofteridis DP; Alexopoulou C; Valachis A; Maraki S; Dimopoulou D; Georgopoulos D; Samonis G
    Clin Infect Dis; 2010 Dec; 51(11):1238-44. PubMed ID: 20973727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial.
    Abdellatif S; Trifi A; Daly F; Mahjoub K; Nasri R; Ben Lakhal S
    Ann Intensive Care; 2016 Dec; 6(1):26. PubMed ID: 27033711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia as part of a macro-project funded by the Seventh Framework Program of the European Commission studying off-patent antibiotics: study protocol for a randomized controlled trial.
    Rosso-Fernández C; Garnacho-Montero J; Antonelli M; Dimopoulos G; Cisneros JM;
    Trials; 2015 Mar; 16():102. PubMed ID: 25872790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
    Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
    Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
    Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.
    Vardakas KZ; Voulgaris GL; Samonis G; Falagas ME
    Int J Antimicrob Agents; 2018 Jan; 51(1):1-9. PubMed ID: 28669836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Ventilator-Associated Pneumonia Using Intravenous Colistin Alone or in Combination with Inhaled Colistin in Critically Ill Children.
    Polat M; Kara SS; Tapısız A; Tezer H; Kalkan G; Dolgun A
    Paediatr Drugs; 2015 Aug; 17(4):323-30. PubMed ID: 25939411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous plus inhaled versus intravenous colistin monotherapy for lower respiratory tract infections: A systematic review and meta-analysis.
    Vardakas KZ; Mavroudis AD; Georgiou M; Falagas ME
    J Infect; 2018 Apr; 76(4):321-327. PubMed ID: 29428226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria.
    Choe J; Sohn YM; Jeong SH; Park HJ; Na SJ; Huh K; Suh GY; Jeon K
    Ther Adv Respir Dis; 2019; 13():1753466619885529. PubMed ID: 31680646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosolized plus intravenous colistin vs intravenous colistin alone for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A retrospective cohort study.
    Almangour TA; Alruwaili A; Almutairi R; Alrasheed A; Alhifany AA; Eljaaly K; Alkofide H; Alhammad AM; Ghonem L; Alsharidi A
    Int J Infect Dis; 2021 Jul; 108():406-412. PubMed ID: 34111542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.
    Paul M; Daikos GL; Durante-Mangoni E; Yahav D; Carmeli Y; Benattar YD; Skiada A; Andini R; Eliakim-Raz N; Nutman A; Zusman O; Antoniadou A; Pafundi PC; Adler A; Dickstein Y; Pavleas I; Zampino R; Daitch V; Bitterman R; Zayyad H; Koppel F; Levi I; Babich T; Friberg LE; Mouton JW; Theuretzbacher U; Leibovici L
    Lancet Infect Dis; 2018 Apr; 18(4):391-400. PubMed ID: 29456043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of adjunctive nebulized colistin sulfate for multidrug-resistant Gram-negative bacteria pneumonia: a retrospective comparative cohort study.
    Bao XL; Tao T; Tang N; Wang YZ; Liao XQ; Huang LL; Ji JJ; Chen X
    Ann Palliat Med; 2022 Sep; 11(9):2939-2951. PubMed ID: 36217623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria.
    Zaidi ST; Al Omran S; Al Aithan AS; Al Sultan M
    J Clin Pharm Ther; 2014 Jun; 39(3):272-6. PubMed ID: 24593154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to treat VAP due to MDR pathogens in ICU patients.
    Garnacho-Montero J; Corcia-Palomo Y; Amaya-Villar R; Martin-Villen L
    BMC Infect Dis; 2014 Nov; 14():135. PubMed ID: 25430700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria.
    Rattanaumpawan P; Lorsutthitham J; Ungprasert P; Angkasekwinai N; Thamlikitkul V
    J Antimicrob Chemother; 2010 Dec; 65(12):2645-9. PubMed ID: 20876621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.